AAVL P2 results, expected soon, may not be as impressive as P1 results were: P1 results were achieved in patients with more severe wet AMD than P2 enrolled: http://www.thestreet.com/story/13182199/1/avalanche-bio-gene-therapy-preview-what-to-expect-from-eye-study.html?